Clinical trial Recruiting at 1 site Observational Ages 18 to 69

Using numerical modeling to diagnose respiratory disorders

Official title: JUNE Project: Does the Modeling of Nasal Airflows Improve the Pathophysiological Understanding and the Diagnosis of Functional Respiratory Disorders?

Run by University Hospital, Bordeaux · NCT06670261 · Data updated 2026-11-12

This study is testing a new way to measure breathing problems caused by nasal blockages to help people with these issues get better diagnoses and avoid unnecessary surgeries.

Quick facts

Study typeObservational
Ages18 Years to 69 Years
SexAll
Enrollment300 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Bordeaux)
StatusRecruiting
StartedJuly 9, 2024
Main results expectedJuly 9, 2026
Study endsJuly 9, 2026
Registry record updatedApril 24, 2025
Trial IDNCT06670261 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include Caucasian individuals aged 18 to 70 with either symptomatic nasal obstruction requiring surgery or asymptomatic individuals with septal deviation.

Probably not a fit

Patients with acute or chronic rhinosinusitis, nasal surgery history, or other significant nasal pathologies may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to objectively measure chronic nasal obstruction (CNO) using computational fluid dynamics simulations to analyze airflow in the nasal cavities. By collecting retrospective clinical and scannographic data, the study seeks to identify specific airflow parameters that correlate with respiratory comfort in both healthy individuals and patients with CNO. The goal is to improve diagnostic accuracy and reduce unnecessary surgeries by providing a reliable measurement of nasal obstruction. The study focuses on patients with nasal obstruction due to septal deviation and other morphological issues.

Why it matters

Potential benefit: If successful, this approach could lead to more accurate diagnoses and better treatment outcomes for patients suffering from chronic nasal obstruction.

How similar studies have gone: While the use of computational fluid dynamics in nasal airflow analysis is a novel approach, similar studies have shown promise in improving diagnostic accuracy for respiratory conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years ≤ age \< 70 years
* BMI \< 30 kg/m2
* Subject or Patient of Caucasian ethnic origin or from the Mediterranean region.
* Asymptomatic subject with or without a septal deviation without sinonasal disease with a NOSE score ≤ 7 Or Patient suffering from chronic nasal obstruction of morphological origin (symptomatic septal or nasoseptal deviation) requiring surgical management with a NOSE score ≥ 9/20, without or .with sleep apnea with an Apnea-hypopnea index ≤ 20 with no other cause than this apnea syndrome

Exclusion Criteria:

* Acute or chronic rhinosinusitis with or without polyps (except controlled allergic rhinitis)
* Vasculitis
* Empty nasal cavity syndrome
* Septal perforations
* History of nasal plastic surgery, sinonasal endoscopic surgery and cancer with head or neck radiotherapy
* Uncontrolled bronchopulmonary pathology
* Treatments with nasal vasomotor repercussions.

Where it's running

  • CHU de Bordeaux
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.